Jared S. Hopkins
Pharma Reporter at The Wall Street Journal
Pharma for @WSJ but I also once interviewed John Oates. [email protected] https://t.co/pMHJnBKbFF
Articles
-
1 week ago |
livemint.com | Chelsey Dulaney |Jared S. Hopkins
Global Summary The shipments have vaulted Ireland, a country of only five million people, into the second-largest goods-trade imbalance with the U.S., trailing only China. This is a Mint Premium article gifted to you. Subscribe to enjoy similar stories. Planes have been jetting from Ireland to the U.S. this year carrying something more valuable than gold: $36 billion worth of hormones for popular obesity and diabetes drugs.
-
1 week ago |
wsj.com | Chelsey Dulaney |Jared S. Hopkins
Planes have been jetting from Ireland to the U.S. this year carrying something more valuable than gold: $36 billion worth of hormones for popular obesity and diabetes drugs. The frantic airlift of those ingredients—more than double what was imported from Ireland for all of last year—reflects the collision of two powerful forces: tariff-driven stockpiling and weight-loss drug demand. Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
-
1 week ago |
fnlondon.com | Chelsey Dulaney |Jared S. Hopkins
How Weight-Loss Drugs Blew Out the U.S. Trade DeficitShipments have propelled Ireland, a country of 5.4 million, to the second-largest goods-trade imbalance with the U.S., behind China Published June 20, 2025 at 5:30 AM ET Planes have been jetting from Ireland to the U.S. this year carrying something more valuable than gold: $36 billion worth of hormones for popular obesity and diabetes drugs.
-
1 week ago |
lopinion.fr | Jared S. Hopkins
Depuis le retour de Donald Trump à la Maison Blanche, des dizaines d’entreprises se sont engagées à augmenter leur production aux Etats-Unis. Mais pas les fabricants de médicaments génériques.
-
1 week ago |
wsj.com | Jared S. Hopkins
June 17, 2025 10:00 am ETDozens of companies have pledged to build more manufacturing in the U.S. since President Trump took office. Generic drugmakers aren’t among them. And they have no plans to change that anytime soon. Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 6K
- Tweets
- 17K
- DMs Open
- Yes
Scoop: Drugmaker Mallinckrodt is talking to hedge funds that lent it money about a plan to file for bankruptcy and avoid paying $1 billion it owes to opioid victims https://t.co/FoczV33AER via @gladstonea @ajsaeedy
RT @eliotwb: 17 Weeks. I took a turn at writing some about Evan in today's print WSJ page devoted to him. check it out here Free Evan.…
Here is a link for the next 24 hours of @WSJ reporter Evan Gershkovich’s colleagues, family and friends reading his journalism - please tune in often to discover his work and share with the world #IStandWithEvan https://t.co/I6n9O5u1TS
